Boyu Hu

No bio available.

Financial relationships

  • Attribution: 
    Self
    Type of financial relationship: 
    Other
    Ineligible company: 
    TG Therapeutics
    Topic: 
    Consulting
    Date added: 
    07/27/2022
    Relationship end date: 
    07/19/2021
  • Attribution: 
    Self
    Type of financial relationship: 
    Other
    Ineligible company: 
    ADC Therapeutics
    Topic: 
    Consulting
    Date added: 
    07/27/2022
    Relationship end date: 
    01/27/2022
  • Attribution: 
    Self
    Type of financial relationship: 
    Other
    Ineligible company: 
    OncLive
    Topic: 
    Advisory Board
    Date added: 
    07/27/2022
    Relationship end date: 
    10/11/2021
  • Attribution: 
    Self
    Type of financial relationship: 
    Other
    Ineligible company: 
    MJH Life Sciences
    Topic: 
    Educational Session on CAR-T
    Date added: 
    07/27/2022
    Relationship end date: 
    05/04/2022
  • Attribution: 
    Self
    Type of financial relationship: 
    Other
    Ineligible company: 
    Bristol Meyer Squibb
    Topic: 
    Advisory Board
    Date added: 
    07/27/2022
    Relationship end date: 
    06/03/2022
  • Attribution: 
    Self
    Type of financial relationship: 
    Other
    Ineligible company: 
    Novartis
    Topic: 
    Advisory Board
    Date added: 
    07/27/2022
    Relationship end date: 
    06/18/2022
  • Attribution: 
    Self
    Type of financial relationship: 
    Grant Or Contract
    Ineligible company: 
    Celgene/BMS
    Topic: 
    Clinical Trial
    Date added: 
    07/27/2022
    Relationship end date: 
    07/15/2024
  • Attribution: 
    Self
    Type of financial relationship: 
    Grant Or Contract
    Ineligible company: 
    CRISPR Therapeutics
    Topic: 
    Clinical Trial
    Date added: 
    07/27/2022
    Relationship end date: 
    08/15/2024
  • Attribution: 
    Self
    Type of financial relationship: 
    Grant Or Contract
    Ineligible company: 
    Morphosys Ag
    Topic: 
    Clinical Trial
    Date added: 
    07/27/2022
    Relationship end date: 
    07/15/2024
  • Attribution: 
    Self
    Type of financial relationship: 
    Grant Or Contract
    Ineligible company: 
    Repare Therapeutics
    Topic: 
    Clinical Trial
    Date added: 
    07/27/2022
    Relationship end date: 
    07/15/2025

Pages

Return to 2022 Cellular Therapy Conference – Translating recent evidence on cellular therapy to real world management of malignancies